Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Video Credit: ANI
Published on January 19, 2021 - Duration: 01:30s

Healthcare workers should be given choice in vaccines: Karnataka resident doctors

Karnataka Association of Resident Doctors (KARD) has demanded the government to let people choose which COVID-19 vaccine, between Pune-based Serum Institute of India's Covishield and Hyderabad-based Bharat Biotech's Covaxin, they want to take.

"Government of India has approved Covishield and Covaxin vaccines.

We have all the reports for Covishield.

But, Covaxin is still in phase-III trials, where the trial is being done on healthcare workers.

We condemn this...Healthcare workers should be given a choice of vaccine," said Dr Dayanand Sagar.

GoI rolled out COVID-19 vaccine jab from January 16.


You are here


💡 newsR Knowledge: Other News Mentions

Karnataka

State in southern India
Awareness campaigns were conducted and hand sanitizers and masks were also distributed to the people, Mallikarjun Radder said.
Credit: DNA - Published 3 hours ago

State health minister K Sudhakar told reporters that one case each of the Delta plus variant was recorded in Bengaluru and Mysuru districts.
Credit: DNA - Published 10 hours ago

The BMTC, KSRTC, and BMRC have released separate statements and appealed to passengers to strictly follow the Covid protocols.
Credit: DNA - Published 3 days ago

The Karnataka government also announced that the night curfew will remain in place across the state between 7 pm to 5 am till further order.
Credit: DNA - Published 4 days ago

Credit: IndiaTimes - Published 4 days ago


Oxford–AstraZeneca COVID-19 vaccine

Vaccine against COVID-19
Credit: IndiaTimes - Published 4 days ago

If Devi continues to show no adverse symptoms, she will be tested for antibodies after 14 days, a senior health official at AIIMS Patna has said.
Credit: DNA - Published 4 days ago

AstraZeneca on Friday backed the idea of keeping a 12-16 weeks gap between the two doses of the Covishield vaccine.
Credit: DNA - Published 4 days ago


Covaxin

Vaccine against COVID-19
Covaxin's data for children after completion of phase two or three trials is expected by September-October.
Credit: DNA - Published 4 hours ago

Bharat Biotech's Covaxin has demonstrated 77.8% efficacy in phase 3 trials, reported ANI quoting sources. The Hyderabad-based firm had earlier submitted the..
Credit: IndiaTimes - Published 1 day ago


Serum Institute of India

Indian biotechnology and biopharmaceuticals company
The new vaccine shall be launched under the brand name of Covovax, which SII is manufacturing in partnership with US pharmaceutical firm Novovax.
Credit: DNA - Published 6 days ago

Serum Institute of India (SII) and Bharat Biotech (BB) are seeking higher prices for Covid-19 vaccines from the Centre amid concerns that the cost of Covishield..
Credit: IndiaTimes - Published 1 week ago

Novavax in collaboration with Indian drug manufacturer Serum Institute of India is manufacturing these vaccines for India and low-income countries.
Credit: DNA - Published 1 week ago

The uncertain path to authorisation in the US for Novavax despite passing the efficacy test with an impressive score of 90.4% might see India emerge as a major..
Credit: IndiaTimes - Published 1 week ago


Hyderabad

Capital of Telangana, India
A Zomato delivery executive was gifted a motorcycle with crowdfunding after one of his clients discovered that he delivers parcels on a bicycle.
Credit: DNA - Published 3 days ago

Corbevax may hold huge potential since the vaccine being developed by Hyderabad-based Biological E may be sold at a low price of Rs 250 for two doses.
Credit: DNA - Published 6 days ago

Hyderabad-based Bharat Biotech's pre-submission meeting has been scheduled on June 23 for evaluation of the World Health Organisation (WHO)'s Emergency Use..
Credit: IndiaTimes - Published 1 week ago



Bharat Biotech

Indian biotechnology company and vaccine manufacturer
Covaxin has inched a step closer to a World Health Organization (WHO) emergency use listing (EUL) with the global body accepting Bharat Biotech’s expression of..
Credit: IndiaTimes - Published 6 days ago


Related videos from verified sources

SHOT SELFIES: Social media fills with 'powerful' COVID vaccine safety message 03:30
Video credit: KTNV Channel 13 Las Vegas - Published on January 30, 2021 

Health Workers Stuck in the Snow Provide COVID-19 Vaccine to Stranded Drivers 02:25
Video credit: CBS4 Miami - Published on January 29, 2021 

Nepal initiates nationwide vaccination drive with jabs for frontline workers 02:27
Video credit: Newsflare STUDIO - Published on January 28, 2021 

You might like